Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
better decrease » greater decrease (Expand Search), teer decrease (Expand Search), between decreased (Expand Search)
Showing 1,401 - 1,420 results of 21,342 for search '(( significantly ((better decrease) OR (mean decrease)) ) OR ( significant decrease decrease ))', query time: 0.40s Refine Results
  1. 1401
    Stereotactic injection of AAV-miR-129-5p suppressed astrocyte activation in depressed mice.

    Stereotactic injection of AAV-miR-129-5p suppressed astrocyte activation in depressed mice. by Qiaozhen Qin (13159201)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1402
    Relationship between miR-129-5p and Mysm1 in depressed mice.

    Relationship between miR-129-5p and Mysm1 in depressed mice. by Qiaozhen Qin (13159201)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1403
    Overexpression of miR-129-5p alleviated depression-like behaviors by increasing ATP content.

    Overexpression of miR-129-5p alleviated depression-like behaviors by increasing ATP content. by Qiaozhen Qin (13159201)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1404
    Overexpression of miR-129-5p alleviated the depressive-like phenotypes of CRS and LPS treated mice.

    Overexpression of miR-129-5p alleviated the depressive-like phenotypes of CRS and LPS treated mice. by Qiaozhen Qin (13159201)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1405
    AZ10606120 treatment significantly increased cytotoxicity and reduced cell number in a dose-dependent manner.

    AZ10606120 treatment significantly increased cytotoxicity and reduced cell number in a dose-dependent manner. by Matthew Drill (22258391)

    Published 2025
    “…Cell numbers were significantly decreased in cells after treatment with AZ10606120 (50µM) compared to both temozolomide (TMZ; 50µM) treatment and untreated controls. …”
    Save to List
    Saved in:
  6. 1406
    Rate of change in salivary amylase pre- and post-VR operation.

    Rate of change in salivary amylase pre- and post-VR operation. by Akihiro Kakimoto (343218)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1407
    Difference in

    Difference in by Akihiro Kakimoto (343218)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1408
    Relationship between the change in

    Relationship between the change in by Akihiro Kakimoto (343218)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1409
    Increase in multiple-choice question scores pre- and post-VR operation.

    Increase in multiple-choice question scores pre- and post-VR operation. by Akihiro Kakimoto (343218)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1410
    Multiple-choice questions and performance pre- and post-VR operation.

    Multiple-choice questions and performance pre- and post-VR operation. by Akihiro Kakimoto (343218)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1411
    Average scores of TDMS-ST pre- and post-VR operation.

    Average scores of TDMS-ST pre- and post-VR operation. by Akihiro Kakimoto (343218)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1412
    VR training system for radiopharmaceutical administration.

    VR training system for radiopharmaceutical administration. by Akihiro Kakimoto (343218)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1413
    Experimental protocol.

    Experimental protocol. by Akihiro Kakimoto (343218)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1414
    Average scores of POMS2 pre- and post-VR operation.

    Average scores of POMS2 pre- and post-VR operation. by Akihiro Kakimoto (343218)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1415
    Blood Pressure and LDL-C During Follow-up.

    Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1416
    Median EQ-5D-3L index values during 5 years of follow-up.

    Median EQ-5D-3L index values during 5 years of follow-up. by Karl Ingard (22582091)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1417
    Baseline Characteristics of Included Patients.

    Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1418
    Subgroup Analysis of the Occurrence of Secondary Endpoints.

    Subgroup Analysis of the Occurrence of Secondary Endpoints. by Karl Ingard (22582091)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1419
    Study flow chart.

    Study flow chart. by Karl Ingard (22582091)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1420
    Kaplan-Meier curve of the primary outcome.

    Kaplan-Meier curve of the primary outcome. by Karl Ingard (22582091)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: